Prenosis Inc. gained U.S. FDA de novo marketing authorization for an artificial intelligence-powered rapid diagnostic tool for sepsis, one of the most challenging and deadly conditions in hospitals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback